STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution



STRATEC Biomedical AG 

08.10.2014 14:27

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


1. Threadneedle Asset Management UK Limited

Threadneedle Asset Management UK Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 6 October 2014, that on 18 April 2013 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 5% and that the percentage of voting rights on that day amounted to 5.35% (628,462 voting rights). Threadneedle Asset Management UK Limited has notified us that these voting rights of 5.35% (628,462 voting rights) are attributable to Threadneedle Asset Management UK Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Asset Management UK Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


2. TAM UK Holdings Limited

TAM UK Holdings Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 6 October 2014, that on 18 April 2013 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 5% and that the percentage of voting rights on that day amounted to 5.35% (628,462 voting rights). TAM UK Holdings Limited has notified us that these voting rights of 5.35% (628,462 voting rights) are attributable to TAM UK Holdings Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to TAM UK Holdings Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.

3. Threadneedle Holdings Limited

Threadneedle Holdings Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 6 October 2014, that on 18 April 2013 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 5% and that the percentage of voting rights on that day amounted to 5.35% (628,462 voting rights). Threadneedle Holdings Limited has notified us that these voting rights of 5.35% (628,462 voting rights) are attributable to Threadneedle Holdings Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Holdings Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


08.10.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  




back